Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine

By Hagiwara Y.   Komase K.   Chen Z.   Matsuo K.   Suzuki Y.   Aizawa C.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2918-2926

Elsevier

Access to resources Recommend Favorite

Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin

By Ohmura M.   Yamamoto M.   Kiyono H.   Fujihashi K.   Takeda Y.   McGhee J.R.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 756-762

Elsevier

Access to resources Recommend Favorite

Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)

By Matsuo K.   Yoshikawa T.   Asanuma H.   Iwasaki T.   Hagiwara Y.   Chen Z.   Kadowaki S.-e.   Tsujimoto H.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2713-2722

Elsevier

Access to resources Recommend Favorite

Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin

By Tamura S.-i.   Ishihara K.   Miyata K.   Aizawa C.   Kurata T.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 339-341

Elsevier

Access to resources Recommend Favorite

Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies

By Yasuda Y.   Isaka M.   Taniguchi T.   Zhao Y.   Matano K.   Matsui H.   Morokuma K.   Maeyama J.-i.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2954-2963

Elsevier

Access to resources Recommend Favorite